Ontology highlight
ABSTRACT: Background
Nearly three-quarters of women experience heavy menstrual bleeding (HMB) during anticoagulation treatment for venous thromboembolism (VTE). HMB can lead to medical interventions, impact school or work and diminish quality of life (QOL). While there are several management options for HMB in patients with VTE, we lack information on how patients approach HMB treatment decisions.Objectives
We examined patients' experience with, perceptions of, and preferences for treatment of HMB while on anticoagulation.Methods
Clinicians and patient advocates developed a web-based survey that was distributed via patient advocacy organizations and social media between May and June 2024, targeting participants 18 years or older who menstruate with a history of VTE and self-r
SUBMITTER: Barnett B
PROVIDER: S-EPMC12424477 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature